使CAR T

Alhomidi Almotiri1

  • 1From the Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Kingdom of Saudi Arabia.

Saudi medical journal
|October 8, 2024
PubMed
概括

化学抗原受体 (CAR) T细胞疗法对急性髓性白血病 (AML) 患者显示出前景. 然而,像"点外瘤"毒性等挑战需要进一步研究,以获得更安全,更有效的治疗方法.